Geode Capital Management
LHDX

Geode Capital Management’s Lucira Health, Inc. Common Stock LHDX Stock Holding History

Geode Capital Management’s Portfolio LHDX Stock Details LHDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-95,621
Closed -$10K – 4886
2022
Q4 		$10K Hold
95,621
– – ﹤0.01% 4843
2022
Q3 		$101K Hold
95,621
– – ﹤0.01% 4574
2022
Q2 		$177K Buy
95,621
+3,545
+4% +$8.62K ﹤0.01% 4347
2022
Q1 		$328K Sell
92,076
-1,360
-1% -$6.68K ﹤0.01% 4145
2021
Q4 		$804K Buy
93,436
+9,349
+11% +$59.5K ﹤0.01% 3814
2021
Q3 		$639K Sell
84,087
-10,586
-11% -$89.3K ﹤0.01% 3913
2021
Q2 		$628K Sell
94,673
-63,392
-40% -$400K ﹤0.01% 3831
2021
Q1 		$1.91M Buy
+158,065
New +$3.14M ﹤0.01% 3272

Other funds holding LHDX

EV
Eclipse Ventures Palo Alto, California $39.6M AUM
Simplex Trading
Simplex Trading Chicago, Illinois $3.23B AUM 62.07% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $18.6B AUM 29.12% 1-Year Est. Return
RA
Resolute Advisors San Francisco, California $242M AUM 52.95% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $280B AUM 33.63% 1-Year Est. Return
CS
Clear Street New York $17.8B AUM 56.26% 1-Year Est. Return